P

Inventor

WANG XILU

US53 patents
⚠️ This page may combine multiple inventors who share the name “WANG XILU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE INC

21 patents
US9174982B2Nov 3, 2015

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC38 citations98
US9029404B2May 12, 2015

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC19 citations92
US8686136B2Apr 1, 2014

Apoptosis promoters

ABBVIE INC20 citations92
US9303025B2Apr 5, 2016

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC11 citations84
US9125913B2Sep 8, 2015

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC10 citations84
US9073855B2Jul 7, 2015

BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC11 citations84
US9072748B2Jul 7, 2015

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC11 citations84
US9045420B2Jun 2, 2015

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

ABBVIE INC11 citations84
US9045444B2Jun 2, 2015

Apoptosis promoters

ABBVIE INC11 citations84
US9403822B2Aug 2, 2016

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC9 citations83
US8940737B2Jan 27, 2015

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC7 citations83
US10676485B2Jun 9, 2020

Macrocyclic MCL-1 inhibitors and methods of use

ABBVIE INC2 citations73
US11897864B2Feb 13, 2024

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC0 citations62
US11786519B2Oct 17, 2023

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC0 citations62
US9844547B2Dec 19, 2017

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC1 citations62
US9266877B2Feb 23, 2016

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC2 citations62
US9227963B2Jan 5, 2016

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC2 citations62
US8889675B2Nov 18, 2014

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC3 citations62
US9359296B2Jun 7, 2016

7-substituted indole Mcl-1 inhibitors

ABBVIE INC1 citations52
US9156856B2Oct 13, 2015

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

ABBVIE INC0 citations52
US9035047B2May 19, 2015

7-substituted indole Mcl-1 inhibitors

ABBVIE INC1 citations52

ABBOTT LAB

17 patents
US7390799B2Jun 24, 2008

Apoptosis promoters

ABBOTT LAB331 citations98
US8354404B2Jan 15, 2013

Apoptosis promoters

ABBOTT LAB39 citations97
US7973161B2Jul 5, 2011

Apoptosis promoters

ABBOTT LAB70 citations97
US7767684B2Aug 3, 2010

Apoptosis promoters

ABBOTT LAB107 citations97
US7709467B2May 4, 2010

Apoptosis promoters

ABBOTT LAB50 citations97
US7642260B2Jan 5, 2010

Apoptosis promoters

ABBOTT LAB82 citations97
US7504512B2Mar 17, 2009

N-acylsulfonamide apoptosis promoters

ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004

N-acylsulfonamide apoptosis promoters

ABBOTT LAB98 citations97
US7449485B2Nov 11, 2008

N-sulfonylurea apoptosis promoters

ABBOTT LAB19 citations93
US7358251B2Apr 15, 2008

N-sulfonylurea apoptosis promoters

ABBOTT LAB19 citations93
US7030115B2Apr 18, 2006

N-sulfonylurea apoptosis promoters

ABBOTT LAB32 citations93
US7906505B2Mar 15, 2011

Apoptosis promoters

ABBOTT LAB18 citations92
US7754886B2Jul 13, 2010

N-acylsulfonamide apoptosis promoters

ABBOTT LAB34 citations90
US7981888B2Jul 19, 2011

1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives

ABBOTT LAB8 citations84
US7777076B2Aug 17, 2010

Macrocyclic inhibitors of BCL proteins

ABBOTT LAB6 citations63
US7323570B2Jan 29, 2008

Farnesyltransferase inhibitors

ABBOTT LAB2 citations62
US7211595B2May 1, 2007

Farnesyltransferase inhibitors

ABBOTT LAB5 citations62

BRUNCKO MILAN

6 patents
US8586754B2Nov 19, 2013

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases

BRUNCKO MILAN100 citations97
US8173811B2May 8, 2012

Apoptosis promoters

BRUNCKO MILAN50 citations97
US8084607B2Dec 27, 2011

Apoptosis promoters

BRUNCKO MILAN43 citations93
US8614318B2Dec 24, 2013

Apoptosis promoters

BRUNCKO MILAN37 citations92

DOHERTY GEORGE A

1 patent
US8557983B2Oct 15, 2013

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

DOHERTY GEORGE A44 citations93

BAELL JONATHAN BAYLDON

1 patent
US8232273B2Jul 31, 2012

Heterocyclic compounds and methods of use

BAELL JONATHAN BAYLDON28 citations91

KUNZER AARON R

1 patent
US8338466B2Dec 25, 2012

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

KUNZER AARON R15 citations80

TAO ZHI-FU

1 patent
US9006247B2Apr 14, 2015

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

TAO ZHI-FU11 citations79

WANG XILU

1 patent
US8445679B2May 21, 2013

7-substituted indole MCL-1 inhibitors

WANG XILU7 citations78

SONG XIAOHONG

1 patent
US8853209B2Oct 7, 2014

1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives

SONG XIAOHONG2 citations57

Showing the top 50 of 53 patents by PatentIndex Score.